$0.201
-0.003[-1.47%]
At close: Apr 26
$0.201
0[0.00%]
After Hours: 5:55PM EDT
CNS Pharma: Insider buying and selling updated today.
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
---|---|---|---|---|---|---|---|---|---|---|
Feb 06, 2024 | Jerzy Gumulka | DIRECTOR | 33.333K | $0.30 | $10.00K | BUY | 344.60% | 43.006K | Feb 01 | View |
Feb 06, 2024 | Anthony Carl Evans | DIRECTOR | 33.333K | $0.30 | $10.00K | BUY | 26666.40% | 33.458K | Feb 01 | View |
Feb 06, 2024 | Christopher Downs | CHIEF FINANCIAL OFFICER | 66.666K | $0.30 | $20.00K | BUY | 181.30% | 103.438K | Feb 01 | View |
Feb 06, 2024 | John Climaco | CHIEF EXECUTIVE OFFICER | 166.666K | $0.30 | $50.00K | BUY | 340.07% | 215.676K | Feb 01 | View |
Aug 23, 2023 | Christopher Downs | CHIEF FINANCIAL OFFICER | 27K | $1.27 | $34.18K | BUY | 276.30% | 36.772K | Aug 22 | View |
Aug 16, 2023 | John M Climaco | CHIEF EXECUTIVE OFFICER | 2.75K | $1.80 | $4.94K | BUY | 5.94% | 49.01K | Aug 16 | View |
Aug 01, 2023 | Waldemar Priebe | -94.298K | $1.41 | -$133.11K | SELL | -37.55% | 156.807K | Dec 06 - Mar 28 | View | |
Apr 21, 2023 | Jerzy Gumulka | DIRECTOR | 2.5K | $1.70 | $4.25K | BUY | 34.85% | 9.673K | Apr 19 | View |
Apr 18, 2023 | Christopher Downs | CHIEF FINANCIAL OFFICER | 3.1K | $3.20 | $9.92K | BUY | 50.40% | 9.251K | Apr 17 | View |
Apr 17, 2023 | Jerzy Gumulka | DIRECTOR | 7.173K | $0.74 | $5.31K | BUY | ∞ | 7.173K | Apr 10 | View |
Apr 14, 2023 | John M Climaco | CHIEF EXECUTIVE OFFICER | 15K | $0.69 | $10.41K | BUY | 49.98% | 45.01K | Apr 12 | View |
Dec 07, 2021 | Christopher Downs | CHIEF FINANCIAL OFFICER | 5K | $0.94 | $4.70K | BUY | 3.41% | 151.5K | Dec 06 | View |
Nov 22, 2021 | Christopher Downs | CHIEF FINANCIAL OFFICER | 4.5K | $1.15 | $5.19K | BUY | 3.17% | 146.5K | Nov 19 | View |
Aug 25, 2020 | Christopher Downs | 142K | $2.04 | $289.68K | PURCHASE | ∞ | 142K | Aug 24 | View |
Browse insider trades on all stocks.